Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

These drug options will be the newer medications, not the outdated formulations sold without a prescription. If your OTC insulin comes in a vial, you will need to purchase syringes to measure and ...

Brokerages have turned bullish over Biocon's growth prospects after the US FDA clearance of the drugmaker's Malaysia unit ...

After the clearance from US drugs regulator, Motilal Oswal has upgraded Biocon to 'buy' with a target price of Rs 430 apiece.

Clearance of Biocon's Malaysia unit puts an end to the drugmaker's regulatory hurdles and opens the door for the approval and ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

The estimated end date is May 2029. In January 2024, investigators at Sheba Medical Center in Israel began a study of the combination of intranasal insulin and the Type 2 diabetes drug semaglutide in ...